LIC sold 33,91,906 ‬ shares, or 2.034% equity, of Dr Reddy’s at an average cost of Rs 5,455.80 crore via open market sale during the period from 11 September 2023 to 22 November 2023.

LIC sold 1,14,23,722 ‬ shares, or 2.033% equity, of Engineers India at an average cost of Rs 118.08 crorevia open market purchase during the period from 16 February 2021 to 22 November 2023.

Dr Reddy's Laboratories is engaged in providing medicines. The firm operates in three segments: global generics, pharmaceutical services and active ingredients (PSAI) and proprietary products.

Engineers India (EIL) is an engineering consultancy and technology licensing company in the fields of hydrocarbons, petrochemicals, fertilizers, metallurgy, ports & terminals, and other sectors of industry, having a DSIR-recognized R&D center. As of 31 March 2023, the Government of India held a 51.32% stake in the company.

LIC has been providing life insurance in India for more than 65 years and is the largest life insurer in the country.

On the BSE, LIC rose 1.47% at Rs 617.80, Dr Reddys shed 0.22% to Rs 5,651.05 and EIL added 1.04% to Rs 146.15.